Numerous efforts have been made to develop a new class of anti-HIV agents that target these coreceptors as an additional or alternative therapy to standard HAART. Among the CCR5 inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback